Drug profile · INN
fosdenopterin
NULIBRY
fosdenopterin (NULIBRY) is an FDA-listed pharmaceutical active ingredient.
EMA: approved Alimentary tract and metabolism (A16) A16AX19
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — fosdenopterin
- Class
- Alimentary tract and metabolism (A16)
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.83
Quick answer
fosdenopterin (NULIBRY) is an FDA-listed pharmaceutical active ingredient.
Key facts
INN fosdenopterin
Brand NULIBRY
Therapeutic class Alimentary tract and metabolism (A16)
ATC code A16AX19
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Related & competitor drugs
Frequently asked questions
What is fosdenopterin?
fosdenopterin (NULIBRY) is an FDA-listed pharmaceutical active ingredient.
What is the brand name for fosdenopterin?
NULIBRY is a marketed brand name for fosdenopterin. Check FDA Drugs@FDA for the current US label holder and prescribing information.